Hemamali Samaratunga
Papers
9
Total Citations
1,462
H-Index
8
About
Hemamali Samaratunga is a distinguished pathologist whose research has profoundly shaped the diagnosis and surgical management of prostate cancer. Working at the intersection of uropathology, advanced imaging, and surgical outcomes, Samaratunga has made landmark contributions through rigorous clinical investigation. Most notably, her involvement in a landmark randomised controlled trial comparing robot-assisted laparoscopic prostatectomy with open radical retropubic prostatectomy yielded findings that have reshaped surgical practice worldwide, with early and 24-month outcome papers accumulating an exceptional 692 and 458 citations respectively. Her work has been instrumental in establishing the evidence base for robotic surgery adoption globally. Beyond surgical outcomes, Samaratunga has pioneered research integrating cutting-edge imaging technologies — particularly PSMA PET/CT and multiparametric MRI — into preoperative staging and lymph-node metastasis prediction. Her contributions to nomogram development and validation help clinicians make more precise, individualised treatment decisions for prostate cancer patients. She has also advanced biopsy methodology, demonstrating the superior accuracy of transperineal over transrectal biopsy approaches. With a cumulative citation record exceeding 1,400 across her most-cited works, Samaratunga's research continues to influence urological oncology practice internationally, making her an essential reference for clinicians and researchers navigating prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9